Recent advances in chemotherapy for advanced prostate cancer

Recently, several important studies have validated prostate-specific antigen (PSA) as a reliable measure of response to chemotherapeutic treatment in advanced hormone-refractory prostate cancer. Furthermore, although chemotherapy in this setting has always been considered palliative, several analyse...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Current urology reports 2000-05, Vol.1 (1), p.48-56
Hauptverfasser:	Olson, K B, Pienta, K J
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Disease Progression Humans Male Prostatic Neoplasms - drug therapy Prostatic Neoplasms - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!